Literature DB >> 19965849

Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis.

Massimiliano Calabrese1, Irene Mattisi, Francesca Rinaldi, Alice Favaretto, Matteo Atzori, Valentina Bernardi, Luigi Barachino, Chiara Romualdi, Luciano Rinaldi, Paola Perini, Paolo Gallo.   

Abstract

BACKGROUND: Although neuropathological observations suggest that cerebellar cortex is a major site of demyelination in multiple sclerosis (MS), only a few MRI studies on cerebellar cortical pathology in MS are available.
OBJECTIVE: To analyse cerebellar cortical volume (CCV) and leucocortical lesions (CL) in MS, and their impact on clinical disability.
METHODS: The authors studied 125 patients divided into 38 Clinical Isolated Syndrome (CIS), 35 relapsing remitting multiple sclerosis (RRMS), 27 secondary progressive multiple sclerosis (SPMS) and 25 primary progressive multiple sclerosis, and 32 normal controls (NC). CCV and cerebellar CL number and volume were evaluated by means of Freesurfer software and Double Inversion Recovery, respectively.
RESULTS: Compared with NC (mean 113.2 + or - 2.6 cm(3)), the CCV was significantly reduced in CIS (105.4 + or - 2.2 cm(3), p=0.018), RRMS (104.0 + or - 2.0 cm(3), p=0.012), SPMS (98.8 + or - 2.0 cm(3), p<0.001) and PPMS (100.6 + or - 2.2 cm(3), p<0.001), even after age, gender and mean cortical volume correction. CL were observed in all patient groups and were an independent predictor of CCV and cerebellar dysfunction. DISCUSSION: The authors confirm that the cerebellar cortex is severely and early affected by MS pathology. The monitoring of cerebellar cortical atrophy and CL may help to understand the mechanism underlying disability progression in MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965849     DOI: 10.1136/jnnp.2009.177733

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET.

Authors:  Valeria T Barletta; Elena Herranz; Costantina A Treaba; Russell Ouellette; Ambica Mehndiratta; Marco L Loggia; Eric C Klawiter; Carolina Ionete; Sloane A Jacob; Caterina Mainero
Journal:  Mult Scler       Date:  2019-04-11       Impact factor: 6.312

2.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

3.  Cerebellar volume loss in radiologically isolated syndrome.

Authors:  Ilena C George; Mohamed Mounir El Mendili; Matilde Inglese; Christina J Azevedo; Orhun Kantarci; Christine Lebrun; Aksel Siva; Darin T Okuda; Daniel Pelletier
Journal:  Mult Scler       Date:  2019-11-04       Impact factor: 6.312

4.  Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration.

Authors:  Wafaa Zaaraoui; Françoise Reuter; Audrey Rico; Anthony Faivre; Lydie Crespy; Irina Malikova; Elisabeth Soulier; Patrick Viout; Yann Le Fur; Sylviane Confort-Gouny; Patrick J Cozzone; Jean Pelletier; Jean-Philippe Ranjeva; Bertrand Audoin
Journal:  J Neurol       Date:  2010-12-04       Impact factor: 4.849

5.  Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.

Authors:  Katrin Weier; Andreas Beck; Stefano Magon; Michael Amann; Yvonne Naegelin; Iris K Penner; Markus Thürling; Volker Aurich; Tobias Derfuss; Ernst-Wilhelm Radue; Christoph Stippich; Ludwig Kappos; Dagmar Timmann; Till Sprenger
Journal:  J Neurol       Date:  2012-06-19       Impact factor: 4.849

6.  Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.

Authors:  Allan J MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Laurie B Morales; Elizabeth Umeda; Benoit Boulat; Russell E Jacobs; Arthur W Toga; Rhonda R Voskuhl
Journal:  J Neurosci Res       Date:  2012-03-13       Impact factor: 4.164

7.  The role of the cerebellum in multiple sclerosis.

Authors:  Katrin Weier; Brenda Banwell; Antonio Cerasa; D Louis Collins; Anne-Marie Dogonowski; Hans Lassmann; Aldo Quattrone; Mohammad A Sahraian; Hartwig R Siebner; Till Sprenger
Journal:  Cerebellum       Date:  2015-06       Impact factor: 3.847

8.  The role of cerebellar damage in explaining disability and cognition in multiple sclerosis phenotypes: a multiparametric MRI study.

Authors:  Raffaello Bonacchi; Alessandro Meani; Elisabetta Pagani; Olga Marchesi; Massimo Filippi; Maria A Rocca
Journal:  J Neurol       Date:  2022-03-01       Impact factor: 4.849

9.  Multicontrast connectometry: a new tool to assess cerebellum alterations in early relapsing-remitting multiple sclerosis.

Authors:  David Romascano; Djalel-Eddine Meskaldji; Guillaume Bonnier; Samanta Simioni; David Rotzinger; Ying-Chia Lin; Gloria Menegaz; Alexis Roche; Myriam Schluep; Renaud Du Pasquier; Jonas Richiardi; Dimitri Van De Ville; Alessandro Daducci; Tilman Sumpf; Jens Fraham; Jean-Philippe Thiran; Gunnar Krueger; Cristina Granziera
Journal:  Hum Brain Mapp       Date:  2014-11-24       Impact factor: 5.038

10.  Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patients.

Authors:  Myrte Strik; L Eduardo Cofré Lizama; Camille J Shanahan; Anneke van der Walt; Frederique M C Boonstra; Rebecca Glarin; Trevor J Kilpatrick; Jeroen J G Geurts; Jon O Cleary; Menno M Schoonheim; Mary P Galea; Scott C Kolbe
Journal:  Brain Commun       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.